That's right. Let's use common sense here. Why on earth would Dr. Rubinfield come on board and make statements such as "MANF has the commercial potential to become a blockbuster drug," if the issue of a delivery system was such a big deal? Do we honestly think Dr. Rubinfield has not considered this before making his noteworthy association with the company?